VVOS Vivos Therapeutics, Inc.
VVOS stock: dilution — what the SEC filings say, updated every weekday morning.
What the filings say Pressure ▼
Less than six months of cash at the latest burn — the company must raise, cut, or both, soon.
Radar 59 (elevated attention) · dilution pressure high · listing risk low · governance risk low · runway 1.1 mo · strongest signal: Runway < 6 months (Jun 30, 2026)
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Get tomorrow's read on VVOS — free One email every weekday morning: what changed across VVOS and ~1,400 other microcaps, every claim linked to the filing.
59 Radar · attention score (0–100)
79 Dilution pressure · financing + balance sheet
0 Listing risk · exchange standards
0 Governance risk · reporting, auditor, going concern
Analyst note No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Pro on VVOS Alerts One email the morning VVOS files anything that matches your rules (types, minimum score, setups).
12-month history Every signal and setup for VVOS back a year, not just 30 days — see how the current setup built.
Full analyst notes What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV All 892 flagged companies, same-day, sortable and exportable.
Balance sheet (XBRL) $1.8M cash + short-term investments as of Jun 30, 2026
1.1 mo estimated runway (annualized 180-day YTD operating cash flow [companyfacts])
$-3.8M stockholders' equity as of Jun 30, 2026
$22.9M public float (10-K cover)
20.1M shares outstanding as of Aug 13, 2026 · was 13.9M May 20, 2026
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 84 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Signal timeline Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
Date Signal Evidence Score Sep 8, 2026 ▼ Unregistered sale 8-K Item 3.02 filed 2026-09-08 (accepted 18:26 ET) filing
35 Sep 8, 2026 ▼ Unregistered sale 8-K Item 3.02 filed 2026-09-08 (accepted 17:29 ET) filing
32 Jun 30, 2026 ▼ Runway < 6 months ~1.1 months runway: liquidity $1,774,000 as of 2026-06-30, burn $18,570,389/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing
44 Jun 30, 2026 ▼ Share count +25% Shares outstanding 13,894,600 (2026-05-20) -> 20,118,023 (2026-08-13), +45% filing
36 Jun 30, 2026 ▼ Negative equity Stockholders' equity $-3,815,000 as of 2026-06-30 filing
31 Jun 30, 2026 ▼ Cash < current liabilities Liquidity $1,774,000 vs current liabilities $20,389,000 filing
22
Quiet Alpha Automated SEC-filing intelligence for US microcaps. Updated every weekday morning from SEC EDGAR · last run 2026-09-22.
Newsletter ·
X ·
[email protected] Quiet Alpha is an automated financial research publication. It is not investment advice, not a recommendation to buy or sell any security, and not personalized to any reader. Data are derived from public SEC filings and may contain errors; verify against the source documents linked in each item. Quiet Alpha accepts no compensation from issuers. Microcap securities are illiquid and can lose most or all of their value.